European Pharmaceutical Review

DECEMBER 23, 2022

Our ambition is to build a modern, industry-leading manufacturing network, by bringing together talented people and cutting-edge processes, technologies and data to reliably deliver high quality, affordable and sustainable medicines and vaccines to patients. Standardise manufacturing .

Manufacturing 81

Manufacturing Networking Medicine Electronics 81

PM360

AUGUST 9, 2022

Biopharma blockbusters in the last 10 years show a disturbing trend. As a top 10 biopharma company leader shared with us, “Real blockbusters are gone. Innovation Is Expanding, But Healthcare Systems Are Slow to Adapt. Driving scale in a slow-moving healthcare ecosystem is not just a challenge for cell and gene therapies.

Biopharma 69

Biopharma Marketing Healthcare Healthcare 69

pharmaphorum

DECEMBER 18, 2022

However, most models are based on an old-fashioned and expensive call centre-based approach that fails to meet the needs of patients and healthcare providers (HCPs) as consumers. Yet, the healthcare experience is antiquated. entertainment or consumer apps), before it is production-worthy for mission-critical healthcare applications.

Biopharma 80

Biopharma Patients Prescription Medical 80

Pharmaceutical Technology

APRIL 24, 2023

Biologics are costly to produce and sell, and the more recent modalities, such as cell and gene therapies, can be difficult to manufacture. With new drugs on the market, companies are now looking for ways to manufacture recently approved biologics, and countries are racing to claim their corner – or maintain their decades-old market share.

Manufacturing 52

Manufacturing Food and Drug Administration Biopharma Sales 52

Pharmaceutical Technology

MAY 9, 2023

Baxter International has signed a definitive agreement to sell its BioPharma Solutions (BPS) business to private equity investor Advent International and growth investor Warburg Pincus, in a deal valued at $4.25bn in cash. The business will offer services from clinical research to commercial deployment for clients.

Manufacturing 97

Manufacturing Biopharma Pharma Healthcare 97

European Pharmaceutical Review

SEPTEMBER 12, 2023

As part of The Future of Pharma/Biopharma Analysis 2023 , which took place on 28-29 June 2023, European Pharmaceutical Review ( EPR ) gathered an expert panel to discuss developing a modern contamination control strategy. Opening the session, moderator Tim Sandle highlighted six fundamental aspects of contamination control.

Consulting 123

Consulting Biopharma Manufacturing Pharmaceutical 123

Pharmaceutical Technology

MARCH 21, 2023

In such turbulent times, ensuring the most efficient and cost-effective manufacturing frameworks becomes even more important. Most pharmaceutical and biotech companies outsource certain production tasks to contract manufacturing organizations (CMOs). SK Biotek is contracted to manufacture the small molecule API.

Manufacturing 59

Manufacturing Pharmaceutical Biopharma FDA 59

European Pharmaceutical Review

SEPTEMBER 15, 2023

The shortlisted finalists of the CPHI awards for 2023 include companies that led by example in sustainable manufacturing, manufacturers and innovators that developed new technologies to advance drug discovery, development and manufacturing.

Pharma 110

Pharma Manufacturing Biopharma Healthcare 110

Pharma Marketing Network

JANUARY 12, 2023

FAIRFIELD, NJ (12 January, 2023) – The Healthcare Businesswomen’s Association (HBA) announces the 2023 Woman of the Year, Honorable Mentor, and STAR. The HBA Woman of the Year award honors a female senior executive whose accomplishments have resulted in significant contributions to the healthcare industry. Jag Dosanjh, President, U.S.

Healthcare 52

Healthcare Healthcare Networking Manufacturing 52

Pharmaceutical Technology

JANUARY 15, 2023

In order to get a therapy to the market, pharma companies often outsource the drug manufacturing to specialist contract manufacturing organizations (CMOs). While Catalent Inc and PCI Pharma Services are in charge of the solid dose and packaging of Lupkynis, Lonza is manufacturing the small molecule API. EMA and NICE news.

Manufacturing 52

Manufacturing Pharmaceutical FDA Pharma 52

Pharmaceutical Technology

SEPTEMBER 13, 2022

The acquisition will expand the international solutions portfolio of AmerisourceBergen aiding in advancing its position as a preferred partner for biopharmaceutical manufacturers. This approach will support its manufacturer partners throughout the pharmaceutical development and marketing processes.

Biopharma 52

Biopharma Manufacturing Pharmaceutical manufacturing Consulting 52

European Pharmaceutical Review

JULY 21, 2023

The company intends to invest approximately $90 million at its site in Ljubljana, Slovenia, to establish a dedicated Sandoz Biopharma Development Center by 2026. They drive competition and cost savings, helping to address the rising financial pressures faced by global healthcare systems.

Biopharma 88

Biopharma Manufacturing Competition Healthcare 88

European Pharmaceutical Review

NOVEMBER 16, 2023

billion by 2032, according to Towards Healthcare. The organisation’s report asserted that growth of the market is being driven by numerous factors including the greater demand for biologics, the expanding biopharmaceutical industry, and the numerous advantages that single-use bioprocessing has over traditional manufacturing methods.

Marketing 74

Marketing Manufacturing Biopharma Competition 74

European Pharmaceutical Review

OCTOBER 2, 2023

Eligible companies classified as start-ups and active in the pharma, biopharma, digital, or medical device sectors can exhibit. Silvia Forroova, Director of partnerships & sustainability, Informa Markets, commented: “We are very excited to be back in Barcelona, one of Europe’s premier biotech and pharma manufacturing hubs.

Manufacturing 96

Manufacturing Pharma Engineering Networking 96

European Pharmaceutical Review

JANUARY 12, 2023

Minimising the use of disposables in the manufacturing process through waste management and recycling. The contract development and manufacturing organisation (CDMO) confirmed it is also working to drive successful decarbonisation by: Committing to 100 percent renewable power through the Climate Group’s RE100 initiative.

Pharma 91

Pharma Biopharma Manufacturing Government 91

Clarivate

AUGUST 8, 2023

The biopharma industry is sweating the long-term implications and warning that it could mean less lifesaving drugs make it to patients going forward. The law was top-of-mind at this summer’s ASCO and BIO meetings, tentpole events in the biopharma conference calendar. The vise on revenues also makes differentiation essential. “The

Biopharma 52

Biopharma Pharma Prescription Manufacturing 52

Scott Burrows

NOVEMBER 2, 2022

Like any other manufactured product, pharma and biopharma products are a sum of…

Pharmaceutical Sales 52

Pharmaceutical Sales Pharmaceutical Sales Biopharma 52

Pharmaceutical Technology

JULY 6, 2022

Other businesses such as Redhill Biopharma or Vincerx Pharma have also announced plans for large layoffs. According to Skillington, the Covid-19 pandemic saw heavy investment in healthcare, and there is likely a certain switch to other directions. Manufacturing or salary discussions are also affected, notes Voigt.

Marketing 129

Marketing Biopharma Pharma Retail 129

Clarivate

MARCH 14, 2024

1] To mitigate the potential presence of nitrosamine impurities in pharmaceuticals, manufacturers are now facing impending regulatory requirements in various markets – in the European Union, for example, they were obligated to submit reformulation strategies and mitigation plans in late 2022. [2].

Pharmaceutical 52

Pharmaceutical Manufacturing Food Healthcare Provider 52

European Pharmaceutical Review

DECEMBER 26, 2023

1 As revolutionary upstream and downstream technologies become a reality, biopharma companies will need to determine how best to integrate them into their current systems. As a result, we can expect to see growing numbers of gene therapy developers and manufacturers adopting new techniques and technologies into their upstream processes.

Manufacturing 83

Manufacturing Safety Patients Competition 83

Clarivate

OCTOBER 25, 2023

What the addition of Part B may bring With the expansion of price negotiations to include Part B drugs in 2028 , Medicare reimbursement may become challenging for additional manufacturers. B&B allows larger practices to negotiate for better reimbursement rates from commercial payers and larger manufacturer discounts/rebates.

Prescription 52

Prescription Physicians Manufacturing Healthcare 52

Clarivate

MAY 14, 2024

Hangzhou Jiuyuan Gene Engineering (owned by Huadong Medicine) is expected to be the first domestic manufacturer to secure approval for their version of the drug once semaglutide goes off-patent in 20264 in Mainland China. Contact us to learn more about the Mainland China healthcare market and disease-specific trends.

Manufacturing 52

Manufacturing Marketing Leads Medicine 52

Pharmaceutical Technology

NOVEMBER 4, 2022

As visibility diminishes, mismanagement of the supply chain can not only lead to revenue and reputational damage for manufacturers but more importantly, loss of life for patients. The expertise in procurement for new projects is a definite advantage with choosing a CMO like Baxter BioPharma Solutions.

Biopharma 52

Biopharma Manufacturing Media Pharmaceutical 52

Pharma Marketing Network

JUNE 17, 2021

The Healthcare Businesswoman’s Association Europe region released an update to its 2018 industry gender pay gap report that shows there is a clear increase in the pay gap between men and women in the life sciences sector in Europe. France and the U.K. reduced the pay gap to 4.8 percent and 5.1

Biopharma 52

Biopharma Healthcare Healthcare Networking 52

PM360

SEPTEMBER 28, 2022

Now, as the President of Accord BioPharma , the U.S. Now that you’re responsible for launching biosimilars in today’s market, what are currently the biggest barriers or issues manufacturers and marketers face that impedes the success of their biosimilar products? specialty division of Intas Pharmaceuticals, Ltd.,

Competition 98

Competition Marketing Biopharma Manufacturing 98

Pharmaceutical Technology

SEPTEMBER 8, 2022

The expert services rendered by them help in improving patient outcomes, minimising costs of the healthcare system, improving medicinal adherence and persistency and saving clinicians’ time. Payer and/or manufacturer reporting. Enrolment in patient assistance programmes and financial assistance. Prescription refill and renewal.

Specialization 45

Specialization Leads Pharma Side effects 45

European Pharmaceutical Review

OCTOBER 19, 2023

billion deal, in which Eli Lilly agreed to acquire two of POINT Biopharma Global’s late-stage radioligand therapies for oncological indications. What is the main challenge in manufacturing alpha therapy radiopharmaceuticals? Recent advancements for radiopharmaceuticals in oncology include a $1.4

Food and Drug Administration 87

Food and Drug Administration Side effects Manufacturing Doctors 87

Pharmaceutical Technology

JULY 7, 2022

There is a lot of excitement that we could be at the start of a new era for the biopharmaceutical industry, with the hope of delivering revolutionary healthcare for previously unaddressed diseases finally becoming a reality. Using a similar treatment to target solid tumours could be the industry’s next major milestone.

Medicine 98

Medicine Transportation Manufacturing Biopharma 98

PM360

AUGUST 24, 2023

Each of their trailblazing efforts result in much more than personal or organization success, it results in better quality of life for patients, better care options for healthcare providers, and happier and healthier people around the world.” Weiss has also made substantial efforts to give back to the community at large.

Marketing 52

Marketing Education Media Healthcare 52

European Pharmaceutical Review

DECEMBER 21, 2022

The healthcare industry is successful in innovating new treatment paradigms ranging from small molecular to biological therapeutics to personalised medicines. The healthcare industry is successful in innovating new treatment paradigms ranging from small molecular to biological therapeutics to personalised medicines.

Manufacturing 74

Manufacturing Pharmaceutical Healthcare Healthcare 74

Pharmaceutical Technology

NOVEMBER 23, 2022

The US still dominates the biopharma sector with more than $378bn in annual drug sales and an approximate capacity of 30% of global manufacturing. Hamilton’s position as a historical steel manufacturer means the city has infrastructure assets that are absent elsewhere. OmniaBio scales CDMO operations in Hamilton.

Marketing 52

Marketing Manufacturing Transportation Government 52

PM360

OCTOBER 3, 2023

Men’s Health: Nuvan Augustin Dassanaike, Senior Vice President Digital and Marketing Strategy & Operations, Accord BioPharma Nephrology/Urology: W. Founder and CEO, ConcentricLife MARKETER OF THE YEAR Conor Fogarty, Marketing Director, Neuroimmunology Franchise, Genentech, Inc. Braun Medical, Inc.

Education 122

Education Marketing Media Management 122

Pharmaceutical Technology

JULY 6, 2022

Other businesses such as Redhill Biopharma or Vincerx Pharma have also announced plans for large layoffs. According to Skillington, the Covid-19 pandemic saw heavy investment in healthcare, and there is likely a certain switch to other directions. Manufacturing or salary discussions are also affected, notes Voigt.

Marketing 64

Marketing Biopharma Pharma Retail 64

Clarivate

JULY 24, 2023

Biopharma and medtech brands made up a dozen of the Clarivate Top 100 New Brands for 2023, as the life science industries continued to show a muscular approach to protecting their intellectual property. Incyte also notches two mentions, first for the U.S.-based

Pharma 52

Pharma Biopharma Prospecting Training 52

PM360

OCTOBER 5, 2023

Now, Real Chemistry is at the forefront of applying analytics, data, and artificial intelligence to the biopharma and healthcare industry and, in 2022, the company achieved its 21st consecutive year of double-digit growth. Weiss has also made substantial efforts to give back to the community at large.

Education 52

Education Marketing Media Biopharma 52

World of DTC Marketing

JUNE 8, 2021

They are going to allow Biogen NINE years for follow-up clinical trials in which time our healthcare system is going to pay a TON of money for hope. Here is what they had to say: “Despite support from patient advocacy groups and pressure from the manufacturer. It hasn’t yet been shown to work.

FDA 207

FDA Food and Drug Administration Patients Biopharma 207

Clarivate

JULY 5, 2023

In 2022, it made its manufacturer, AbbVie, $21.2bn. This strategy is often chosen by the brand manufacturers who offer higher rebates at the net price level in exchange for better placement on formularies. The Biosimilars Forum has hailed 2022 as a watershed year that could create a more competitive U.S. The current U.S.

Marketing 97

Marketing Physicians Manufacturing Competition 97